a public good project by the
Synthesis
Company
of California

© 2026

Steven G. Hughes | doi.page

0 works0 citations0 h-index

Steven G. Hughes

Electronic BioSciences (United States)(US)

Publications by Year

Research Areas

Aquaculture Nutrition and Growth, Amyloidosis: Diagnosis, Treatment, Outcomes, Aquaculture disease management and microbiota, Lipid metabolism and disorders, Fish Ecology and Management Studies

Most-Cited Works

→ Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis(2018)1,389 cited
→ A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking(2009)841 cited
→ Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials(2016)733 cited
→ Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome(2019)646 cited
→ Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides(2017)574 cited
→ Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia(2015)520 cited
→

Targeting APOC3 in the Familial Chylomicronemia Syndrome

(2014)

486 cited

→ Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study(2015)460 cited

→ AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer(2015)433 cited

→ STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial(2018)282 cited